Relaxin therapy for atrial fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a drug called relaxin can improve outcomes for people with atrial fibrillation who are having a catheter ablation (a procedure to correct an irregular heartbeat). It aims to see if relaxin helps the heart recover better after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have atrial fibrillation (an irregular heartbeat) and be scheduled for a catheter ablation (a procedure to fix the heartbeat).
- You cannot have permanent atrial fibrillation or a complete heart block.
- Your atrial fibrillation cannot be caused by a temporary issue like a thyroid problem.
- You cannot be taking or plan to take heart rhythm medications during or after the ablation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication, AP31969, to control heart rhythm in people with atrial fibrillation. It compares the drug to a placebo to see if it can reduce how often AF episodes happen over time.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
This study investigates whether a catheter ablation procedure can improve wellbeing and reduce the risk of serious events for people 80 and older with symptomatic atrial fibrillation. The goal is to see if this treatment offers better outcomes than standard care in this age group.
This study tests whether adding acupuncture can help prevent atrial fibrillation from coming back after a heart ablation procedure. It aims to lower the chance of irregular heartbeats in the months following treatment.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
Hear when a new Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.